Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
2017 · BMC Cancer · 16 citations
https://doi.org/10.1186/s12885-017-3204-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
221
Citations
7
h-index
7
i10-index
R.W. Pfirrmann is an academic researcher. The author has contributed to research in topics: Cancer therapeutics and mechanisms & Phenothiazines and Benzothiazines Synthesis and Activities & Chemical Synthesis and Analysis. The author has an h-index of 7, co-authored 18 publications.
Click to start Chat